Related Content
Search Google Scholar for:
|
|
Science 15 May 1964: Vol. 144. no. 3620, pp. 862 - 863 DOI: 10.1126/science.144.3620.862
|
|
Articles
Antiviral Activity of 1-Adamantanamine (Amantadine)
W. L. Davies 1,
R. R. Grunert 1,
R. F. Haff 1,
J. W. McGahen 1,
E. M. Neumayer 1,
M. Paulshock 1,
J. C. Watts 1,
T. R. Wood 1,
E. C. Hermann 1, and
C. E. Hoffmann 1
1 Pharmaceutical Research Division, Industrial and Biochemicals Department, E. I. du Pont de Nemours and Company, Wilmington, Delaware
I-Adamantanamine (amantadine) causes a selective, reproducible, dose-related inhibition of influenza infections in tissue culture, chick embryos, and mice. The compound is not virucidal and appears to act by interfering with the penetration of the host cell by the virus. In influenza infections of mice, greatest efficacy occurs with treatment at the time of infection; however, there is significant antiviral activity with treatment delayed up to 72 hours after infection. Virus inhibition is not complete and survivors are immune to a challenge infection with the original infecting virus.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition.
- Y. Ohigashi, C. Ma, X. Jing, V. Balannick, L. H. Pinto, and R. A. Lamb (2009)
PNAS
106, 18775-18779
| Abstract »
| Full Text »
| PDF »
- Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation.
- A. C. Hurt, J. K. Holien, M. Parker, A. Kelso, and I. G. Barr (2009)
J. Virol.
83, 10366-10373
| Abstract »
| Full Text »
| PDF »
- Identification of the Pore-lining Residues of the BM2 Ion Channel Protein of Influenza B Virus.
- C. Ma, C. S. Soto, Y. Ohigashi, A. Taylor, V. Bournas, B. Glawe, M. K. Udo, W. F. DeGrado, R. A. Lamb, and L. H. Pinto (2008)
J. Biol. Chem.
283, 15921-15931
| Abstract »
| Full Text »
| PDF »
- The M2 Proton Channels of Influenza A and B Viruses.
- L. H. Pinto and R. A. Lamb (2006)
J. Biol. Chem.
281, 8997-9000
| Full Text »
| PDF »
- Amantadine Inhibits NMDA Receptors by Accelerating Channel Closure during Channel Block.
- T. A. Blanpied, R. J. Clarke, and J. W. Johnson (2005)
J. Neurosci.
25, 3312-3322
| Abstract »
| Full Text »
| PDF »
- Voltage-Gated Proton Channels and Other Proton Transfer Pathways.
- T. E. Decoursey (2003)
Physiol Rev
83, 475-579
| Abstract »
| Full Text »
| PDF »
- Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection.
- C. Sweet, K. J. Jakeman, K. Bush, P. C. Wagaman, L. A. Mckown, A. J. Streeter, D. Desai-Krieger, P. Chand, and Y. S. Babu (2002)
Antimicrob. Agents Chemother.
46, 996-1004
| Abstract »
| Full Text »
| PDF »
- Amantadine Inhibits Nicotinic Acetylcholine Receptor Function in Hippocampal Neurons.
- H. Matsubayashi, K. L. Swanson, and E. X. Albuquerque (1997)
J. Pharmacol. Exp. Ther.
281, 834-844
| Abstract »
| Full Text »
- Present status and future prospects for HIV therapies.
- M. Johnston and D. Hoth (1993)
Science
260, 1286-1293
| Abstract »
| PDF »
- Reversible Pathologic Jealousy (Othello Syndrome) Associated With Amantadine.
- P. McNamara and R. Durso (1991)
J Geriatr Psychiatry Neurol
4, 157-159
| Abstract »
| PDF »
- Antiviral Drugs in Pediatrics.
- H. H. Balfour Jr and J. A. Englund (1989)
Arch Pediatr Adolesc Med
143, 1307-1316
| Abstract »
| PDF »
- Sculpting horizons in organic chemistry.
- B. Trost (1985)
Science
227, 908-916
| Abstract »
| PDF »
- The Effect of Amantadine on Arousal and EEG Patterns in Creutzfeldt-Jakob Disease.
- M. G. Terzano, E. Montanari, S. Calzetti, D. Mancia, and A. Lechi (1983)
Arch Neurol
40, 555-559
| Abstract »
| PDF »
- Prevention of Russian Influenza by Amantadine.
- A. S. Monto, R. A. Gunn, M. G. Bandyk, and C. L. King (1979)
JAMA
241, 1003-1007
| Abstract »
| PDF »
- Amantadine: neuromuscular blockade by suppression of ionic conductance of the acetylcholine receptor.
- E. Albuquerque, A. Eldefrawi, M. Eldefrawi, N. Mansour, and M. Tsai (1978)
Science
199, 788-790
| Abstract »
| PDF »
- Prevention and Control of Influenza by Chemoprophylaxis and Chemotherapy: Prospects From Examination of Recent Experience.
- G. G. Jackson and E. D. Stanley (1976)
JAMA
235, 2739-2742
| Abstract »
| PDF »
- Evaluation of Amantadine in Artificially Induced A2 and B Influenza.
- A. A. Smorodintsev, D. M. Zlydnikov, A. M. Kiseleva, J. A. Romanov, A. P. Kazantsev, and V. I. Rumovsky (1970)
JAMA
213, 1448-1454
| Abstract »
| PDF »
- Amantadine-Dopamine Interaction: Possible Mode of Action in Parkinsonism.
- R. P. Grelak, R. Clark, J. M. Stump, and V. G. Vernier (1970)
Science
169, 203-204
| Abstract »
| PDF »
- Evaluation of Therapeutic Efficacy of Amantadine in Patients With Naturally Occurring A2 Influenza.
- Y. Togo, R. B. Hornick, V. J. Felitti, M. L. Kaufman, A. T. Dawkins Jr., V. E. Kilpe, and J. L. Claghorn (1970)
JAMA
211, 1149-1156
| Abstract »
| PDF »
- Studies on Induced Influenza in Man: I. Double-Blind Studies Designed to Assess Prophylactic Efficacy of Amantadine Hydrochloride Against A2/Rockville/1/65 Strain.
- Y. Togo, R. B. Hornick, and A. T. Dawkins Jr. (1968)
JAMA
203, 1089-1094
| Abstract »
| PDF »
- Effect of Amantadine Hydrochloride on the Response of Human Lymphocytes to Phytohemagglutinin.
- W. E. Rawls, J. L. Melnick, G. B. Olson, P. B. Dent, and R. A. Good (1967)
Science
158, 506-507
| Abstract »
| PDF »
- Amantadine Hydrochloride: Analysis of Data Related to Its Proposed Use for Prevention of A2 Influenza Virus Disease in Human Beings.
- A. B. Sabin (1967)
JAMA
200, 943-950
| Abstract »
| PDF »
- 1-Adamantanamine Hydrochloride: Inhibition of Rous and Esh Sarcoma Viruses in Cell Culture.
- A. M. Wallbank, R. E. Matter, and N. G. Klinikowski (1966)
Science
152, 1760-1761
| Abstract »
| PDF »
|
|